OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-11 Cr | ₹-8.73 Cr | ₹1.66 Cr | ₹1.46 Cr | ₹1.34 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-11 Cr |
| Mar2024 | ₹-8.73 Cr |
| Mar2023 | ₹1.66 Cr |
| Mar2022 | ₹1.46 Cr |
| Mar2021 | ₹1.34 Cr |
How is Deferred Tax Assets / Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-11 Cr | Negative | |
| Mar2024 | ₹-8.73 Cr | Negative | |
| Mar2023 | ₹1.66 Cr | 13.55 | |
| Mar2022 | ₹1.46 Cr | 9.03 | |
| Mar2021 | ₹1.34 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹184.3 Cr | 3% | -6.8% | -37.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 3% |
-6.8% |
-37.5% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses